Stay updated with breaking news from Pharma Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ERYTECH Provides Update on the Announced Combination with PHERECYDES Entry into a definitive merger agreement between ERYTECH and PHERECYDESCompletion... | May 15, 2023
ERYTECH Provides Update on the Announced Combination with PHERECYDES Entry into a definitive merger agreement between ERYTECH and PHERECYDESCompletion of a contribution in kind of PHERECYDES
ERYTECH Provides Business and Financial Update for the First Quarter of 2023 Combination with Pherecydes, intending to create a global leader in extended phage therapies to target antimicrobial
Press ReleaseNicox's Partner Ocumension Therapeutics Receives Priority Review Status for ZERVIATE New Drug Application in China Nicox's partner, Ocumension Therapeutics, announced on April
ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market Cambridge, MA (U.S.) and Lyon (France), April 17, 2023 - ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage